Catalent, Inc.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Techno…
Drug Manufacturers - Specialty & Generic
US, Somerset [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&A Details · Industry · Urgent
M&A Deals · Breakdown
Catalent, Inc. has no acquisition track records yet.
M&A Deals · History
Catalent, Inc. has no acquisition track records yet.
M&A Deals · Within Industry
No current deals within Drug Manufacturers - Specialty & Generic Industry.
M&A Deals · Latest
Act, dont react; Track the most urgent M&A deals across all industries
Details
Details
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
Details
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00